Tomonari Shigemura1, Norimoto Kobayashi1, Kazunaga Agematsu2, Osamu Ohara3, Yozo Nakazawa4. 1. Department of Pediatrics, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. 2. Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Matsumoto, Japan. 3. Department of Technology Development, Kazusa DNA Research Institute, Chiba, Japan. 4. Department of Pediatrics, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. yxnakaza@shinshu-u.ac.jp.
Abstract
PURPOSE: We report normal neutrophil count in a mother, who carries the same ELANE mutation as her daughter with severe congenital neutropenia. We hypothesized that the mother possessed wild- and mutant-type clones and the wild-type clones could generate neutrophils, whereas the mutant clones could not. METHODS: We confirmed mutant variant ratio by sequence signals and measured the frequency of the mutant allele by subcloning in various cell types. We established the ELANE-mutated and non-mutated induced pluripotent stem cells (iPSCs) from the mother's T cells and compared granulopoiesis between these iPSCs. RESULTS: In the sequence analysis of isolated peripheral blood (PB), nail and hair, the mutant variant was detected in approximately 40-60% of lymphocytes, monocytes, hematopoietic progenitor cells, and hair as well as in a small percentage of nail, but in none of the neutrophils. In the subcloning analysis of extracted DNA from CD3+ and CD34+ cells, the mutant allele was identified in 37.5% and 38.1%, respectively. We reprogrammed the mother's PB cells and established the ELANE-mutated and non-mutated iPSCs. Granulopoiesis from mutated iPSCs revealed little sensitivity to granulocyte colony-stimulating factor in comparison with non-mutated iPSCs. CONCLUSIONS: These observations strongly suggest that mutant-carrying neutrophils did not appear in the mother's PB because mutated clones could not differentiate into neutrophils. The mother's normal hematological phenotype could be explained by the perseverance of normal, non-mutated granulopoiesis.
PURPOSE: We report normal neutrophil count in a mother, who carries the same ELANE mutation as her daughter with severe congenital neutropenia. We hypothesized that the mother possessed wild- and mutant-type clones and the wild-type clones could generate neutrophils, whereas the mutant clones could not. METHODS: We confirmed mutant variant ratio by sequence signals and measured the frequency of the mutant allele by subcloning in various cell types. We established the ELANE-mutated and non-mutated induced pluripotent stem cells (iPSCs) from the mother's T cells and compared granulopoiesis between these iPSCs. RESULTS: In the sequence analysis of isolated peripheral blood (PB), nail and hair, the mutant variant was detected in approximately 40-60% of lymphocytes, monocytes, hematopoietic progenitor cells, and hair as well as in a small percentage of nail, but in none of the neutrophils. In the subcloning analysis of extracted DNA from CD3+ and CD34+ cells, the mutant allele was identified in 37.5% and 38.1%, respectively. We reprogrammed the mother's PB cells and established the ELANE-mutated and non-mutated iPSCs. Granulopoiesis from mutated iPSCs revealed little sensitivity to granulocyte colony-stimulating factor in comparison with non-mutated iPSCs. CONCLUSIONS: These observations strongly suggest that mutant-carrying neutrophils did not appear in the mother's PB because mutated clones could not differentiate into neutrophils. The mother's normal hematological phenotype could be explained by the perseverance of normal, non-mutated granulopoiesis.
Authors: Peter E Newburger; Talia N Pindyck; Zhiqing Zhu; Audrey Anna Bolyard; Andrew A G Aprikyan; David C Dale; Gary D Smith; Laurence A Boxer Journal: Pediatr Blood Cancer Date: 2010-08 Impact factor: 3.167
Authors: Ramesh C Nayak; Lisa R Trump; Bruce J Aronow; Kasiani Myers; Parinda Mehta; Theodosia Kalfa; Ashley M Wellendorf; C Alexander Valencia; Patrick J Paddison; Marshall S Horwitz; H Leighton Grimes; Carolyn Lutzko; Jose A Cancelas Journal: J Clin Invest Date: 2015-07-20 Impact factor: 14.808
Authors: Phil J Ancliff; Rosemary E Gale; Michael J Watts; Ri Liesner; Ian M Hann; Stephan Strobel; David C Linch Journal: Blood Date: 2002-07-15 Impact factor: 22.113
Authors: Timothy Tidwell; Jeremy Wechsler; Ramesh C Nayak; Lisa Trump; Stephen J Salipante; Jerry C Cheng; Jean Donadieu; Taly Glaubach; Seth J Corey; H Leighton Grimes; Carolyn Lutzko; Jose A Cancelas; Marshall S Horwitz Journal: Blood Date: 2013-11-01 Impact factor: 22.113
Authors: Nina B Gold; Steven M Harrison; Jared H Rowe; Jessica Gold; Elissa Furutani; Alessandra Biffi; Christine N Duncan; Akiko Shimamura; Leslie E Lehmann; Robert C Green Journal: HGG Adv Date: 2021-09-25